ARVINAS, INC. Shareholders' Equity
ARVINAS, INC. (ARVN) had Shareholders' Equity of $562.20 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-04
- 2026-06-30: Stockholders' Equity Attributable to Parent $562.20M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $386.80M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $433.90M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $564.40M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $562.20M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $386.80M 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $433.90M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $564.40M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $609.30M 10-Q · filed 2026-08-04 | |
| 2025-03-31 | $660.10M 10-Q · filed 2026-08-04 | |
| 2024-12-31 | $561.70M 10-Q · filed 2026-08-04 | |
| 2024-09-30 | $586.00M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $600.20M 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $609.70M 10-Q · filed 2025-08-06 | |
| 2023-12-31 | $660.00M 10-K · filed 2026-02-24 | |
| 2023-09-30 | $457.20M 10-Q · filed 2024-10-30 | |
| 2023-06-30 | $463.60M 10-Q · filed 2024-10-30 | |
| 2023-03-31 | $511.00M 10-Q · filed 2024-07-30 | |
| 2022-12-31 | $564.90M 10-K · filed 2026-02-24 | |
| 2022-09-30 | $621.50M 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $670.60M 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $723.30M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $781.70M 10-K · filed 2025-02-11 | |
| 2021-09-30 | $817.70M 10-Q · filed 2022-11-09 | $817.74M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $582.90M 10-Q · filed 2022-11-09 | $582.95M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $615.20M 10-Q · filed 2022-08-04 | $615.30M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $642.20M 10-K · filed 2024-02-27 | $642.26M 10-K · filed 2021-03-01 |
| 2020-09-30 | $205.12M 10-Q · filed 2021-11-03 | |
| 2020-06-30 | $197.78M 10-Q · filed 2021-11-03 | |
| 2020-03-31 | $211.71M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $226.60M 10-K · filed 2023-02-23 | $226.69M 10-K · filed 2020-03-16 |
| 2019-09-30 | $134.16M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $116.51M 10-Q · filed 2020-11-05 | $116.51M 10-Q · filed 2019-08-05 |
| 2019-03-31 | $127.74M 10-Q · filed 2020-08-04 | $127.74M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $136.60M 10-K · filed 2022-02-28 | $136.67M 10-K · filed 2019-03-26 |
| 2018-09-30 | -$278.84M 10-Q · filed 2019-11-04 | |
| 2018-06-30 | -$158.52M 10-Q · filed 2019-11-04 | |
| 2018-03-31 | -$136.78M 10-Q · filed 2019-08-05 | |
| 2017-12-31 | -$61.23M 10-K · filed 2021-03-01 | |
| 2017-09-30 | -$52.02M 10-Q · filed 2018-11-14 | |
| 2016-12-31 | -$32.88M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |